Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

FA Klok, G Toenges, AC Mavromanoli… - The Lancet …, 2021 - thelancet.com
Background Current guidelines recommend a risk-adjusted treatment strategy for the
management of acute pulmonary embolism. This is a particular patient category for whom …
被引用次数：14 相关文章

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial.

FA Klok, G Toenges, AC Mavromanoli… - The Lancet …, 2021 - europepmc.org
Background Current guidelines recommend a risk-adjusted treatment strategy for the
management of acute pulmonary embolism. This is a particular patient category for whom …

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

FA Klok, G Toenges… - Lancet …, 2021 - scholarlypublications …
Background Current guidelines recommend a risk-adjusted treatment strategy for the
management of acute pulmonary embolism. This is a particular patient category for whom …

[引用][C] Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 …

FA Klok, G Toenges, AC Mavromanoli, S Barco… - 2021 - publications.goettingen-research …

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

FA Klok, G Toenges, AC Mavromanoli… - THE LANCET …, 2021 - cris.unibo.it
BACKGROUND: Current guidelines recommend a risk-adjusted treatment strategy for the
management of acute pulmonary embolism. This is a particular patient category for whom …

[引用][C] Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 …

FA Klok, G Toenges, AC Mavromanoli… - The Lancet …, 2021 - portalcientifico.uah.es
Background: Current guidelines recommend a risk-adjusted treatment strategy for the
management of acute pulmonary embolism. This is a particular patient category for whom …

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

FA Klok, G Toenges, AC Mavromanoli… - THE LANCET …, 2021 - irinsubria.uninsubria.it
Background: Current guidelines recommend a risk-adjusted treatment strategy for the
management of acute pulmonary embolism. This is a particular patient category for whom …

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

FA Klok, G Toenges, AC Mavromanoli, S Barco… - The Lancet …, 2021 - Elsevier
Background Current guidelines recommend a risk-adjusted treatment strategy for the
management of acute pulmonary embolism. This is a particular patient category for whom …

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

FA Klok, AC Mavromanoli, S Barco, M Lankeit… - The Lancet …, 2021 - elibrary.ru
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary
embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial КОРЗИНА …

Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial

FA Klok, G Toenges, AC Mavromanoli… - The Lancet …, 2021 - zora.uzh.ch
BACKGROUND Current guidelines recommend a risk-adjusted treatment strategy for the
management of acute pulmonary embolism. This is a particular patient category for whom …